Description: IXICO plc is a brain health company. The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Parkinson's disease, behavioral health and adolescent mental health. It is a provider of clinical trials services to pharmaceutical companies. Its products include Assessa, mehealth, MyBrainBook and TrialTracker. Assessa is a decision-support tool for healthcare professionals looking to diagnose dementia and detect the underlying causes. mehealth is an online software for clinicians at the point-of-care to support decision making and improve the monitoring and treatment of patients. MyBrainBook is a digital platform to improve the quality of life and service delivery for people living with dementia and their supporters. TrialTracker is a Web-based system that allows users to track their imaging-based research study or clinical trial in real time. It is also collaborating with partners to develop companion digital health products.
Home Page: ixico.com
IXI Technical Analysis
Griffin Court
London,
EC1A 9PN
United Kingdom
Phone:
44 20 3763 7499
Officers
Name | Title |
---|---|
Mr. Giulio Cerroni | CEO & Director |
Mr. Grant Nash | CFO, Company Sec. & Exec. Director |
Prof. Daniel Rueckert | Co-Founder & Member of Scientific Advisory Board |
Prof. Derek Lionel Glendon Hill | Co-Founder and Pres of Regulatory Science & External Relations |
Prof. David Hawkes | Co-Founder & Member of Scientific Advisory Board |
Prof. Joseph Hajnal | Co-Founder & Member of Scientific Advisory Board |
Mr. Marcus Thornton | Chief Operating Officer |
Mr. Mark Austin | Director of Technology |
Dr. Robin Wolz | Chief Scientific Officer |
Ms. Hannah Esfahanian | HR Mang. |
Exchange: LSE
Country: UK : United Kingdom
Currency: Pence sterling (p)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Life Sciences Tools & Services |
GIC Sub-Industry: | Life Sciences Tools & Services |
Forward PE: | 178.5714 |
---|---|
Trailing PE: | 12.25 |
Price-to-Book MRQ: | 1.0021 |
Price-to-Sales TTM: | 1.4485 |
IPO Date: | 1996-04-25 |
Fiscal Year End: | September |
Full Time Employees: | 90 |